Nanjiang Hou

G‐CSF is not necessary to maintain over 99% dose–intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10‐year analysis

Andrew M. Evens, Jeffrey Cilley, Taylor M. Ortiz et al. · British Journal of Haematology · 2007 · 85 citations

Medicine, Hematology, Oncology +15

Acceptance of tamoxifen chemoprevention by physicians and women at risk

Julia Tchou, Nanjiang Hou, Alfred Rademaker et al. · Cancer · 2004 · 85 citations · Full text

Medicine, Oncology, Preventive Medicine +14

Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women

Robert T. Chatterton, Esnar T. Mateo, Nanjiang Hou et al. · Journal of Endocrinology · 2005 · 83 citations · Full text

Medicine, Endocrinology, Hormone Biochemistry +16

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long‐term follow‐up in newly diagnosed mantle cell lymphoma

Andrew M. Evens, Jane N. Winter, Nanjiang Hou et al. · British Journal of Haematology · 2007 · 47 citations

Medicine, Hematology, Oncology +14

A prospective study of variability in mammographic density during the menstrual cycle

Monica Morrow, Robert T. Chatterton, Alfred Rademaker et al. · Breast Cancer Research and Treatment · 2009 · 35 citations

Medicine, Gynecology, Radiology +15